Clinical pharmacy in onco-hematology and bone marrow transplant: A valuable contribution to improving patient safety
| Autor: | Marília Berlofa Visacri, Cristina R. Barbosa, Patricia Moriel, Natalia Cangussu Duarte, Mariane Tavares |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Bone marrow transplant Hematology business.industry Pharmacists 030226 pharmacology & pharmacy Clinical pharmacy 03 medical and health sciences Patient safety 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Internal medicine medicine Humans Medication Errors Pharmacology (medical) Patient Safety Prospective Studies Pharmacy Service Hospital Intensive care medicine business Pharmacist intervention Bone Marrow Transplantation |
| Zdroj: | Journal of Oncology Pharmacy Practice. :107815522094396 |
| ISSN: | 1477-092X 1078-1552 |
| DOI: | 10.1177/1078155220943964 |
| Popis: | Introduction It is known that clinical pharmacists intercept prescribing errors and contribute to patient safety in several medical specialties. The aim of this study was to identify, quantify and classify prescribing errors and pharmacist interventions carried out in onco-hematology and bone marrow transplant inpatient units. Methods This was a prospective and quantitative study, conducted from February 2018 to July 2018 in onco-hematology and bone marrow transplant inpatient units of a tertiary teaching hospital in Brazil. A pharmacist detected prescribing errors and performed interventions. The type and incidence of prescribing errors, error severity, type of pharmacist interventions, potential impact of interventions in patient care, and intervention acceptance rates were evaluated. Results A total of 1172 prescriptions were evaluated, 9% of them contained errors (total of 135 errors), and the most common error was related to prescribing the wrong dose (31.8%). Wrong dose and omission of drug were the two most frequent errors in onco-hematology, while wrong dose followed by inappropriate dilution were the most frequent in bone marrow transplantation. The pharmacist performed 135 interventions and the most common intervention was related to the treatment regimen (41.5%). Serious errors and very significant pharmacist interventions were the most frequent in both inpatient units. The acceptance rate of pharmacist interventions was high (90%). Conclusions Clinical pharmacy improves patient safety and quality of care in onco-hematology and bone marrow transplant inpatient units. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|